New Haven, CTNCT02193295Now EnrollingIRB Ready

Insulin Resistance Clinical Trial in New Haven, CT

Access cutting-edge insulin resistance treatment through this clinical trial at a research site in New Haven. Study-provided care at no cost to qualified participants.

Sponsored by Yale University

Quick Self-Assessment

See if you qualify for this New Haven location

Preparing your pre-screening questions…

Expert Care in New Haven

Access insulin resistance specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related insulin resistance treatment provided free

Apply for This New Haven Location

Check if you qualify for this insulin resistance clinical trial in New Haven, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New Haven

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New Haven site if eligible
  4. 4Begin participation

About This Insulin Resistance Study in New Haven

The purpose of this study is to examine whether weight reduction decreases intramyocellular (IMCL) and hepatic lipid content, and improves insulin sensitivity of muscle and fat tissue in people who are insulin resistant and have a family history of type 2 diabetes. Hepatic mitochondrial oxidation will be assesses using a 3 hour triple tracer study (D7 glucose, 3-13C lactate and 13C4 beta-hydroxybutyrate).

Sponsor: Yale University

Who Can Participate

Inclusion Criteria

Healthy, sedentary, non-smoking and not taking any medications other than birth control pills.
Hematocrit \>35%
Subjects will have no systemic or organ disease including diabetes.
Subjects will have no history eating disorders.
Women must be using a form of birth control (sexual abstinence, birth control pills, Norplant, IUD or condoms) and will be studied between day 0 and 7 of their menstrual cycle.
Those who are taking birth control pills or have had a hysterectomy may be studied at any time.
Physical activity will be assessed using a standard questionnaire with an activity index cut off at 2.3.

Exclusion Criteria

Any subject, who does not fit the inclusion criteria. Including history of eating disorders, any systemic and organ disease including diabetes. Lactose intolerance Any blood count, clotting abnormalities HYpertriglyceridemeia (TG over 100 mg/dL)
Hematocrit \<35%.
Women of childbearing potential, who are not using contraception (as mentioned above) or who are not abstinent.
Subjects who have a regular exercise regimen will not be enrolled.
Metal implants and/or body piercing, which cannot be removed before the MR studies.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New Haven?

Yes, this clinical trial (NCT02193295) has an active research site in New Haven, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Insulin Resistance Treatment Options in New Haven, CT

If you're searching for insulin resistance treatment options in New Haven, CT, this clinical trial (NCT02193295) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New Haven research site is actively enrolling participants for this clinical trial. You'll receive care from experienced insulin resistance specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all insulin resistance clinical trials near you to find additional studies recruiting in your area.

More Metabolic Syndrome Trials in New Haven, CT

See all metabolic syndrome clinical trials recruiting in New Haven — not just this study.

Browse Metabolic Syndrome Trials in New Haven →

Browse More Trials by Condition

Ready to Join in New Haven?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New Haven, CT